{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:40:54Z","timestamp":1792500054855,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,25]]},"abstract":"<jats:p>To explore the risk factors for in-stent restenosis (ISR) after stent implantation in patients with coronary heart disease (CHD) using logistic regression analysis. From February 2020 to February 2022, 350 patients with CHD after percutaneous coronary intervention (PCI) were divided into a stent stenosis group and a stent nonstenosis group based on coronary angiography results performed 2 years after PCI. Univariate and multivariate logistic regressions were used to analyze the factors related to ISR after coronary stent implantation in patients with CHD. This study was approved by the Ethics Committee of Shandong University of Traditional Chinese Medicine. Patient signed informed consent. Of the 350 patients with CHD, 138 (39.43%) had stent restenosis while 212 did not. Univariate analysis showed that a family history of CHD, history of type 2 diabetes, hypertension, smoking, and drinking, discontinuation of aspirin, use of conventional dose statins, calcified lesions,\u2005\u2265\u20053 implanted stents, stent length\u2005\u2265\u200530\u2009mm, stent diameter\u2005&lt;\u20053\u2009mm, and tandem stent increased the risk of restenosis. The incidence of restenosis was higher in the stent group than that in the nonstent group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). There were no significant differences in the blood lipid level, left ventricular ejection fraction, clopidogrel\/ticagrelor or beta-blocker withdrawal, location of culprit vessels, and thrombotic lesions between the 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Multivariate logistic regression analysis showed that family history of CHD, history of type 2 diabetes, hypertension, smoking, and drinking, aspirin withdrawal, use of conventional doses of statins, calcified lesions,\u2005\u2265\u20053 implanted stents, stent length\u2005\u2265\u200530\u2009mm, stent diameter\u2005&lt;\u20053\u2009mm, and tandem stenting were risk factors for ISR within 2 years after PCI. A family history of CHD, history of type 2 diabetes, hypertension, smoking, and drinking, discontinuation of aspirin, use of conventional dose statins, calcified lesions,\u2005\u2265\u20053 stent implantations, stent length\u2005\u2265\u200530\u2009mm, stent diameter\u2005&lt;\u20053\u2009mm, and tandem stenting are risk factors for ISR within 2 years after PCI in patients with CHD.<\/jats:p>","DOI":"10.1097\/md.0000000000031707","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T20:15:06Z","timestamp":1669839306000},"page":"e31707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":36,"title":["Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study"],"prefix":"10.1097","volume":"101","author":[{"given":"Juan","family":"Zhang","sequence":"first","affiliation":[{"name":"The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Jinan, China"},{"name":"Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Bian","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-8965","authenticated-orcid":false,"given":"Yi-Tao","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"637","article-title":"Coronary in-stent restenosis: predictors and treatment.","volume":"118","author":"Ullrich","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1109\/TBME.2021.3082172","article-title":"Non-invasive treatment for coronary in-stent restenosis via wireless revascularization with nitinol active stent.","volume":"68","author":"Ang","year":"2021","journal-title":"IEEE Trans Biomed Eng"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"20942094","DOI":"10.3390\/cells11132094","article-title":"Restenosis after coronary stent implantation: cellular mechanisms and potential of endothelial progenitor cells (a short guide for the interventional cardiologist).","volume":"11","author":"Gori","year":"2022","journal-title":"Cells"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1093\/eurheartj\/ehz731","article-title":"Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.","volume":"41","author":"Lansky","year":"2020","journal-title":"Eur Heart J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"110361","DOI":"10.1016\/j.jbiomech.2021.110361","article-title":"Effects of local coronary blood flow dynamics on the predictions of a model of in-stent restenosis.","volume":"120","author":"Zun","year":"2021","journal-title":"J Biomech"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ccd.29225","article-title":"Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.","volume":"98","author":"Wiebe","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10867-021-09571-y","article-title":"Local hemodynamic analysis after coronary stent implantation based on Euler-Lagrange method.","volume":"47","author":"Wang","year":"2021","journal-title":"J Biol Phys"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm-2021-1089","article-title":"Association between LDL\/HDL ratio and in-stent restenosis in patients with acute coronary syndrome after stent implantation.","volume":"16","author":"Fang","year":"2022","journal-title":"Biomark Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4068\/cmj.2017.53.3.203","article-title":"Identification of risk factors influencing in-stent restenosis with acute coronary syndrome presentation.","volume":"53","author":"Cho","year":"2017","journal-title":"Chonnam Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jacc.2020.06.082","article-title":"Drug-coated balloons for in-stent restenosis.","volume":"76","author":"Kereiakes","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jacc.2020.06.081","article-title":"In-stent restenosis: a second chance to get it right.","volume":"76","author":"Shlofmitz","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e007109","DOI":"10.1161\/CIRCINTERVENTIONS.118.007109","article-title":"The therapeutic dilemma of recurrent in-stent restenosis.","volume":"11","author":"Alfonso","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R13-20250504","first-page":"205","article-title":"Logistic regression analysis of factors related to coronary stent restenosis after stent implantation in patients with coronary atherosclerotic heart disease.","volume":"26","author":"Lu","year":"2020","journal-title":"Hebei Med"},{"key":"R14-20250504","first-page":"2451","article-title":"Influencing factors of developing in-stent restenosis within 2 years after percutaneous coronary intervention in patients with coronary heart disease.","volume":"41","author":"Hou","year":"2019","journal-title":"Guangxi Med J"},{"key":"R15-20250504","first-page":"1946","article-title":"Relevant factors of in-stent restenosis after percutaneous coronary intervention with drug-eluting stents.","volume":"36","author":"Zhang","year":"2020","journal-title":"J Pract Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacc.2020.06.040","article-title":"Lipoprotein(a) and family history predict cardiovascular disease risk.","volume":"76","author":"Mehta","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurjpc\/zwab163","article-title":"Editor comment: focus on arterial hypertension and coronary artery disease.","volume":"28","author":"Halasz","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e27481","DOI":"10.1097\/MD.0000000000027481","article-title":"The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: a retrospective study.","volume":"100","author":"Zheng","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"n1537","DOI":"10.1136\/bmj.n1537","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:10:34Z","timestamp":1746335434000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":19,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031707","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]}}}